The Vue+ study will evaluate 400 presbyopic subjects for three years. The investigators for Phase I included Dr. Stephen Slade of the Slade & Baker Vision Center in Houston, Jon Dishler of the Dishler Laser Institute in Greenwood Village, Colorado. RVO anticipates that Dr. Dan Tran, of the Coastal Laser Eye Center in Newport Beach, California, Y Ralph Chu of the Chu Vision Institute in Minneapolis, Minnesota, the Discover Vision Center in Leawood, Kansas, Dr. John Olkowski of EyeSight Vision Institute, Honolulu, Robert Lehmann of the Lehmann Eye Center in Nacogdoches, cornea.
The investigators versions Phase One Of FDA Clinical TrialReVision Optics , a leader in the research, development and manufacture of implantable medical devices assist assist patients reading glasses reading glasses, announced that it has enrollment first follow completed during Phase I of the U.S. Study for the extension for the extension. The clinical trial is to study the PresbyLens, recently renamed Vue+, for the improvement the near vision in patients with presbyopia, the age-related loss of near vision.. Continue reading “The Vue+ study will evaluate 400 presbyopic subjects for three years.”